GrantQuick

health · HHS-CDC-HHSCDCERA

Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

Centers for Disease Control and Prevention - ERA · RFA-TS-26-165

Closed

Award Range

$0$500K

Total Program Funding

$4.5M

Expected Awards

3

Deadline

June 10, 2026

GRANTQUICK SUMMARYPlain-English Overview

Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS). Centers for Disease Control and Prevention - ERA. CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures are encouraged. Funding will be for four funding options: Option A -... up to $500,000 per award; $4,500,000 total program funding; ~3 awards expected.

Who Should Apply

Public universities/colleges, State governments, Unrestricted (any eligible entity), County governments, Special district governments (+9 more)

Who Should NOT Apply

Few restrictions — most eligible entities can apply

Key Requirements (Plain English)

  • Additional Eligibility Information to be included in the NOFO
  • Deadline: 2026-06-10

💡 GrantQuick Tip

High-value award — invest significantly in proposal quality. Consider hiring a grant writer.

Competitiveness: Very high — extremely limited awards available

What This Grant Funds

CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures are encouraged. Funding will be for four funding options: Option A - Support research with strong existing evidence such as studies on known environmental or genetic risk factors, research that improves past studies with better data, or investigations linking risk factors to ALS diagnosis and treatment; Option B - Support new and exploratory research on ALS risk factors such as studies on risk factors with little existing evidence or research using innovative methods; Option C - Understand ALS risk in affected populations, such as studies involving military veterans or investigations of ALS risk factors impacting this population; Option D - Analyze biological samples from the Guamanian ALS cluster such as investigation of disease mechanisms and environmental factors, exposure routes, genetic studies and biomarkers and how this could lead to mitigation therapeutics, diagnostics or prevention.

Attachments

Who Can Apply

Additional Eligibility Information to be included in the NOFO.

Eligible Applicant Types

Public Colleges & UniversitiesState GovernmentsUnrestricted (open to all)County GovernmentsSpecial District GovernmentsFederally Recognized Tribal Governments501(c)(3) NonprofitsIndependent School DistrictsPublic And Indian Housing AuthoritiesPrivate Colleges & UniversitiesOther (see NOFO for details)Nonprofits without 501(c)(3)Other Tribal OrganizationsCity/Township Governments

Funding Details

Maximum Award
$500K
Total Program Funding
$4.5M
Expected Number of Awards
3
Cost Sharing Required?
No
Funding Instrument
cooperative_agreement

Key Dates

Posted: May 11, 2026
Application Deadline: June 10, 2026 (0 days remaining)

Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.

Agency Contact

Dr. Candis Hunter ncipc_erpo@cdc.gov

ncipc_erpo@cdc.gov

Ready to apply?

View the full NOFO and submit your application on Grants.gov